Peptides for Skin Rejuvenation: GHK-Cu, Collagen Peptides & Growth Factor Research

Introduction: The Science of Peptide-Based Skin Rejuvenation

The skin is the body’s largest organ, and its aging is among the most visible and extensively studied aspects of human biology. Over the past two decades, peptides for skin rejuvenation have emerged as one of the most promising areas of dermatological research, offering targeted mechanisms for addressing collagen loss, elastin degradation, oxidative damage, and impaired wound healing that characterize aging skin.

Unlike broad-spectrum topical agents that work through general antioxidant or exfoliating mechanisms, bioactive peptides interact with specific cellular receptors and signaling pathways to modulate gene expression, stimulate matrix protein synthesis, and activate repair cascades. This targeted approach has made peptides the subject of intense research interest — from small copper-binding tripeptides like GHK-Cu to complex growth factor peptides and multi-component formulations like the Glow peptide blend.

This comprehensive guide examines the biology of skin aging, the mechanisms and evidence for key skin rejuvenation peptides, delivery method science, comparisons with conventional anti-aging ingredients, and research protocol design. Whether you are a dermatological researcher, a peptide scientist, or a clinician seeking to understand the evidence behind peptide-based skin rejuvenation, this resource aims to provide a thorough, evidence-based overview.

Note: All information is provided for research and educational purposes only. Peptides discussed are sold for laboratory research use only and are not intended for human consumption unless otherwise noted.

Skin Aging Biology: Understanding What Peptides Must Address

Before examining individual peptides, it is essential to understand the biological processes that drive skin aging. These processes represent the targets that rejuvenation peptides must address.

Collagen Loss: The Central Feature of Skin Aging

Collagen constitutes approximately 75-80% of the dry weight of human dermis, providing the structural framework that gives skin its firmness, elasticity, and tensile strength. Beginning around age 25, collagen synthesis decreases by approximately 1-1.5% per year, while collagen degradation (mediated by matrix metalloproteinases, or MMPs) continues unabated. By age 60, the average person has lost approximately 40-50% of their dermal collagen compared to their peak in early adulthood (Varani et al., 2006; PMID: 16675963).

The skin contains several collagen types, each with distinct functions:

Collagen Type	Location	Function	Age-Related Changes
Type I	Dermis (80-85% of dermal collagen)	Tensile strength, structural framework	Decreased synthesis, increased fragmentation
Type III	Dermis (10-15% of dermal collagen), wound healing	Tissue elasticity, wound repair scaffold	Reduced ratio to Type I, slower wound healing
Type IV	Basement membrane	Dermal-epidermal junction integrity	Thinning, reduced adhesion, blister susceptibility
Type VII	Anchoring fibrils	Connects dermis to epidermis	Decreased production, skin fragility
Type XVII	Hemidesmosomes	Epithelial cell adhesion	Loss contributes to stem cell depletion

Effective skin rejuvenation peptides must stimulate new collagen synthesis while simultaneously reducing the activity of collagen-degrading enzymes (MMPs). GHK-Cu is particularly notable in this regard, as it both upregulates collagen production and modulates MMP activity.

Elastin Degradation

Elastin fibers provide the skin’s ability to stretch and recoil. Unlike collagen, which is continuously synthesized and degraded throughout life, elastin is primarily produced during development and early life, with very limited adult synthesis. This means that elastin damage is essentially irreversible under normal conditions — damaged elastic fibers are replaced by disorganized, non-functional elastotic material rather than by new functional elastin (Uitto et al., 1989; PMID: 2661918).

Solar elastosis — the accumulation of degraded, tangled elastin fibers in photo-damaged skin — is a hallmark of photoaging. UV radiation activates neutrophil elastase and MMP-12, which degrade functional elastin. Peptides that inhibit elastase activity or stimulate tropoelastin production (the soluble elastin precursor) represent promising approaches to addressing elastin loss.

Photoaging vs. Intrinsic Aging

Skin aging is driven by two overlapping but mechanistically distinct processes:

Feature	Intrinsic (Chronological) Aging	Extrinsic (Photo) Aging
Primary cause	Telomere shortening, mitochondrial dysfunction, hormonal decline	UV radiation (UVA and UVB), pollution, smoking
Clinical appearance	Fine wrinkles, thin skin, gradual laxity	Deep wrinkles, coarse texture, dyspigmentation, leathery quality
Collagen changes	Gradual decrease in synthesis	MMP-mediated destruction + decreased synthesis
Elastin changes	Gradual loss of elasticity	Solar elastosis (elastin fiber degradation and accumulation)
Pigmentation	Even pallor	Lentigines, mottled hyperpigmentation
Key molecular drivers	Reduced growth factors, cellular senescence, mitochondrial DNA damage	ROS generation, NF-?B activation, AP-1 transcription factor, MMP upregulation
Reversibility	Limited	Partially reversible with treatment

Effective peptide-based rejuvenation strategies must address both intrinsic and extrinsic aging pathways. This typically requires a multi-peptide approach, as different peptides target different aspects of the aging cascade. For a broader discussion of peptides in aging skin, see our guides on peptides for aging skin and peptides for skin aging and wrinkles.

The Senescence-Associated Secretory Phenotype (SASP)

As skin cells accumulate damage and reach replicative senescence, they adopt the Senescence-Associated Secretory Phenotype (SASP) — a pro-inflammatory, pro-degradative secretory profile that includes elevated IL-6, IL-8, MMP-1, MMP-3, and other factors that degrade surrounding tissue. Senescent cells essentially accelerate the aging of their neighbors through paracrine signaling, creating a feed-forward cycle of tissue degradation.

Peptides that can modulate the SASP — either by reducing pro-inflammatory signaling, suppressing MMP activity, or promoting the clearance of senescent cells — represent an emerging frontier in skin rejuvenation research. GHK-Cu has shown particular promise in this area through its broad gene expression modulatory effects.

GHK-Cu: The Master Skin Rejuvenation Peptide

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex first identified in human plasma by Dr. Loren Pickart in 1973. Found at concentrations of approximately 200 ng/mL in young adults (declining to approximately 80 ng/mL by age 60), GHK-Cu has emerged as one of the most extensively studied peptides in skin rejuvenation research, with effects that extend far beyond simple collagen stimulation (Pickart et al., 2012; PMID: 23019022).

Gene Expression Modulation: The Broadest Peptide Effect Known

In 2010, a landmark Broad Institute Connectivity Map analysis revealed that GHK modulates the expression of 4,000+ human genes — approximately 6% of the human genome (Pickart et al., 2012; PMID: 23019022). This makes GHK-Cu the single most broadly gene-modulatory peptide identified to date. The gene expression changes are overwhelmingly in a direction consistent with “younger” tissue function:

• 31 genes involved in collagen synthesis — upregulated
• Antioxidant defense genes — upregulated (including SOD1, SOD2, SOD3)
• DNA repair genes — upregulated (including GADD45A, XPC, ERCC1)
• Pro-inflammatory and tissue-destructive genes — downregulated (including IL-6, TNF-?, multiple MMPs)
• Fibrosis-promoting genes — downregulated (including TGF-?1, CTGF in fibrotic contexts)
• Ubiquitin/proteasome pathway genes — modulated (improved protein quality control)

This comprehensive gene expression profile suggests that GHK-Cu does not simply stimulate one or two pathways — it essentially resets a broad network of age-related gene expression changes toward a more youthful pattern. This “resetting” effect is consistent with the observation that GHK-Cu levels are higher in young plasma and decline with age.

Collagen Synthesis Stimulation

GHK-Cu stimulates the production of multiple collagen types in dermal fibroblasts:

• Type I collagen — the primary structural collagen, increased by approximately 70% in vitro (Maquart et al., 1999; PMID: 10188958)
• Type III collagen — the “wound healing” collagen that provides initial scaffold for repair
• Type IV collagen — basement membrane collagen critical for dermal-epidermal junction integrity

Simultaneously, GHK-Cu modulates MMP (matrix metalloproteinase) activity in a context-dependent manner. In healthy tissue, it inhibits excessive MMP-1 (collagenase) and MMP-2 (gelatinase) activity that drives collagen degradation. However, in fibrotic or scarred tissue, it promotes controlled MMP-mediated remodeling to break down excess scar collagen. This bidirectional regulation is similar to the contextual NO modulation seen with BPC-157 and is key to GHK-Cu’s ability to promote organized tissue architecture.

Superoxide Dismutase (SOD) Activation

Oxidative stress is a central driver of skin aging. Reactive oxygen species (ROS) generated by UV radiation, pollution, and normal metabolic processes damage DNA, proteins, and lipids, and activate MMP-mediated collagen destruction via the AP-1 transcription factor pathway. The body’s primary defense against superoxide radicals is the superoxide dismutase (SOD) enzyme family.

GHK-Cu upregulates all three SOD isoforms:

• SOD1 (Cu/Zn-SOD) — cytoplasmic, protects intracellular structures
• SOD2 (Mn-SOD) — mitochondrial, protects against mitochondrial ROS
• SOD3 (EC-SOD) — extracellular, protects the extracellular matrix from oxidative damage

By enhancing the cell’s intrinsic antioxidant capacity, GHK-Cu provides a fundamentally different form of oxidative protection than topical antioxidants like vitamin C or vitamin E, which act as sacrificial electron donors. GHK-Cu upregulates the enzymatic machinery that continuously neutralizes ROS, providing sustained, self-renewing antioxidant defense.

Wound Healing and Tissue Remodeling

GHK-Cu accelerates wound healing through multiple convergent mechanisms:

• Fibroblast activation — increased proliferation, migration, and collagen production
• Angiogenesis — promotes VEGF expression and endothelial cell migration for wound vascularization
• Nerve regeneration — supports sensory nerve regrowth in wounded skin
• Glycosaminoglycan (GAG) synthesis — increases dermal GAG content (hyaluronic acid, dermatan sulfate), improving tissue hydration and structure
• Anti-inflammatory signaling — reduces excessive inflammatory infiltration while maintaining necessary immune surveillance

In a controlled clinical study, application of GHK-Cu cream to standardized wounds resulted in faster wound closure, increased collagen deposition, and improved scar quality compared to placebo (Leyden et al., 2002). These wound healing effects are directly relevant to post-procedural skin recovery and for researchers studying healing enhancement, complementing agents like BPC-157 and TB-500. For more on peptides and skin healing, see peptides for skin healing and scars.

Anti-Inflammatory Properties

Chronic low-grade inflammation (“inflammaging”) is increasingly recognized as a key driver of skin aging. GHK-Cu demonstrates potent anti-inflammatory effects:

• Suppression of pro-inflammatory cytokines: IL-6, TNF-?, IL-1?
• Reduction of NF-?B activation
• Decreased oxidative burst activity in neutrophils
• Modulation of TGF-? signaling toward anti-inflammatory (non-fibrotic) phenotypes

These anti-inflammatory properties are particularly relevant for sensitive or rosacea-prone skin research, where chronic inflammation accelerates visible aging. The anti-inflammatory profile of GHK-Cu complements its collagen-stimulating effects by addressing inflammation as a root cause of matrix degradation rather than simply replacing lost collagen.

GHK-Cu vs. Retinol: A Detailed Comparison

Retinol (vitamin A) has long been considered the gold standard of anti-aging skincare ingredients. GHK-Cu offers several mechanistic advantages and differences. For a dedicated analysis, see our comprehensive GHK-Cu vs. retinol comparison.

Factor	GHK-Cu	Retinol/Retinoic Acid
Mechanism	Gene expression modulation (4000+ genes), collagen synthesis, SOD activation	RAR/RXR nuclear receptor activation, cell turnover increase
Collagen effect	Direct stimulation of Types I, III, IV collagen + MMP inhibition	Indirect via procollagen gene expression + MMP-1 inhibition
Antioxidant	Endogenous SOD upregulation (enzymatic, self-renewing)	Weak direct antioxidant, primarily signals through nuclear receptors
Irritation potential	Very low (naturally occurring in skin)	High (retinoid dermatitis common, especially at initiation)
Photosensitivity	No increase	Yes — increases UV sensitivity, requires SPF
Wound healing	Accelerates healing (pro-migratory, angiogenic)	Impairs healing at high concentrations (anti-proliferative)
Gene scope	4,000+ genes modulated	~300-500 genes modulated
Pregnancy safety	Not studied (research compound)	Contraindicated (teratogenic)
Tolerance buildup	Not observed	Retinization period (2-6 weeks of irritation)

Copper Peptide Topical Application Science

The efficacy of topical GHK-Cu depends on effective delivery through the stratum corneum — the skin’s outermost barrier layer. As a small tripeptide (molecular weight ~403 Da with copper), GHK-Cu is near the upper limit of passive percutaneous absorption (typically <500 Da), giving it better inherent penetration than larger peptides.

Penetration Enhancement Strategies

Method	Mechanism	Enhancement Factor	Practicality
Liposomal encapsulation	Lipid vesicles fuse with stratum corneum	3-10x	High (available in commercial formulations)
Microneedling	Creates microchannels bypassing stratum corneum	10-100x	Moderate (requires device, technique)
Iontophoresis	Electrical current drives charged peptides into skin	5-20x	Low (requires equipment)
Chemical enhancers	Disrupt lipid bilayers (e.g., DMSO, ethanol, surfactants)	2-5x	High but may cause irritation
Hyaluronic acid vehicle	Hydration-mediated barrier softening	1.5-3x	High (compatible, non-irritating)
Nanoparticle carriers	Size-dependent penetration + sustained release	5-15x	Moderate (emerging technology)

Optimal Concentrations for Topical Research

Published studies on topical GHK-Cu have used concentrations ranging from 0.01% to 1%. The most commonly studied concentration range is 0.1-0.5%, which balances efficacy with cost and stability considerations. Higher concentrations have not shown proportional increases in efficacy, suggesting a plateau effect consistent with receptor saturation kinetics.

In a 12-week double-blind study, 0.4% GHK-Cu cream applied twice daily produced statistically significant improvements in fine lines, overall skin texture, and skin density (as measured by ultrasound) compared to vehicle control (Leyden et al., 2002). Notably, GHK-Cu outperformed vitamin K oxide cream and was comparable to retinoic acid cream in several outcome measures — without the irritation associated with retinoids.

Collagen Peptide Types and Their Roles in Skin Rejuvenation

Beyond GHK-Cu, several other peptide categories play important roles in collagen-based skin rejuvenation. Understanding the different collagen types and the peptides that target them is essential for designing comprehensive rejuvenation protocols.

Type I Collagen Peptides

Type I collagen is the predominant structural protein in skin, and its loss is the single most significant contributor to visible aging (wrinkles, sagging, thinning). Peptides that stimulate Type I collagen synthesis include:

• Palmitoyl pentapeptide-4 (Matrixyl) — the KTTKS sequence is a fragment of Type I procollagen that acts as a matrikine, signaling fibroblasts to produce new collagen. In vitro, Matrixyl increased Type I collagen synthesis by up to 117% (Katayama et al., 1993; PMID: 8245302). This mechanism represents a “feedback” signal — the collagen degradation fragment itself triggers new collagen production.
• Palmitoyl tripeptide-1 (Pal-GHK) — the lipophilic derivative of GHK, designed for enhanced skin penetration. The palmitoyl group increases membrane permeability while the GHK sequence retains its collagen-stimulating bioactivity.
• Acetyl hexapeptide-3 (Argireline) — while primarily known as a neuromuscular peptide (“Botox in a bottle”), it also stimulates Type I collagen synthesis through independent fibroblast signaling.

Type III Collagen Peptides

Type III collagen is the “repair” collagen — it forms the initial provisional matrix during wound healing and is the predominant collagen in fetal skin (explaining its softness). In aged skin, the Type III/Type I ratio decreases, contributing to reduced suppleness. Peptides that enhance Type III collagen include:

• GHK-Cu — stimulates both Type I and Type III simultaneously, improving the structural ratio
• Palmitoyl tripeptide-5 (Syn-Coll) — activates TGF-? signaling, which drives both Type I and Type III procollagen gene expression
• BPC-157 — in wound healing studies, BPC-157 has shown effects on Type III collagen production, contributing to initial wound matrix formation before Type I remodeling occurs

Type VII Collagen and the Dermal-Epidermal Junction

Type VII collagen forms the anchoring fibrils that connect the dermis to the epidermis. Loss of Type VII collagen with age leads to dermal-epidermal junction weakening, skin fragility, and impaired barrier function. This is clinically visible as increased bruising susceptibility and the “tissue paper” quality of aged skin.

• Palmitoyl tetrapeptide-7 — reduces IL-6 secretion, which indirectly preserves Type VII collagen by reducing inflammatory degradation at the junction
• Matrixyl 3000 — a combination of palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7, targeting both deep dermal collagen and junction integrity simultaneously

Growth Factor Peptides in Skin Rejuvenation

Growth factors are naturally occurring proteins that regulate cell proliferation, differentiation, and migration. In skin biology, several growth factors play critical roles in maintaining tissue homeostasis and driving repair. Peptide mimetics and fragments of these growth factors represent a frontier in skin rejuvenation research.

Epidermal Growth Factor (EGF)

EGF binds to EGFR (Epidermal Growth Factor Receptor) on keratinocytes and fibroblasts, stimulating cell proliferation and wound re-epithelialization. In aged skin, EGF levels and EGFR density both decline, contributing to slower cell turnover and impaired barrier repair.

Topical EGF has been studied in:

• Post-laser resurfacing recovery (accelerated healing, reduced erythema duration)
• Chronic wound healing (diabetic ulcers, venous stasis ulcers)
• Anti-aging applications (improved skin texture, pore size, and fine lines)

A 2013 split-face study demonstrated that a cream containing recombinant human EGF (rhEGF) applied for 8 weeks produced significant improvements in periorbital wrinkle depth and skin elasticity compared to the control side (Shin et al., 2013; PMID: 24049263). However, concerns about EGF’s potential to stimulate proliferation in pre-neoplastic cells have limited enthusiasm for high-concentration topical EGF products.

Fibroblast Growth Factor (FGF)

FGFs (particularly FGF-1 and FGF-2/bFGF) are potent stimulators of fibroblast proliferation, collagen synthesis, and angiogenesis. In skin rejuvenation research:

• bFGF (FGF-2) has been extensively studied for wound healing enhancement and scar prevention. In clinical studies of burn wounds, topical bFGF accelerated healing and improved scar quality (Akita et al., 2008; PMID: 18385634).
• FGF fragments — smaller peptide sequences derived from FGF that retain receptor-binding activity without the mitogenic potency of full-length FGF. These offer a potentially safer alternative to full-length growth factors for cosmetic applications.

Transforming Growth Factor Beta (TGF-?)

TGF-? is a central regulator of extracellular matrix production, playing a dual role in skin biology:

• Beneficial effects: stimulates collagen I, III, and IV synthesis; promotes glycosaminoglycan production; enhances tissue inhibitors of metalloproteinases (TIMPs)
• Potentially adverse effects: excessive TGF-?1 signaling drives fibrosis (hypertrophic scarring, keloid formation)

The key to harnessing TGF-? for skin rejuvenation is contextual modulation — promoting its matrix-building effects while preventing its fibrotic potential. GHK-Cu achieves this balance naturally, as do peptides like Syn-Coll (palmitoyl tripeptide-5) that activate TGF-? at physiological levels rather than supraphysiological concentrations.

Hepatocyte Growth Factor (HGF) and Keratinocyte Growth Factor (KGF)

HGF and KGF (FGF-7) promote epithelial cell proliferation and migration, contributing to barrier repair and epidermal renewal. While less commonly incorporated into topical peptide products, these growth factors play important roles in post-procedural recovery protocols and are relevant to understanding the comprehensive growth factor landscape of skin repair.

The Glow Peptide Blend: Multi-Peptide Approach to Skin Rejuvenation

The Glow peptide blend from Proxiva Labs represents a multi-component approach to skin rejuvenation research, combining complementary peptides in a single formulation. This approach is grounded in the principle that skin aging is a multi-factorial process requiring multi-target intervention.

The rationale for multi-peptide blends in skin research includes:

• Pathway coverage — different peptides target different aspects of skin aging (collagen loss, oxidative stress, inflammation, barrier dysfunction)
• Temporal coordination — some peptides act rapidly (e.g., anti-inflammatory signals) while others require sustained exposure (e.g., collagen synthesis stimulation)
• Dose optimization — lower doses of multiple complementary peptides may achieve superior results to high doses of a single peptide, with fewer side effects
• Synergistic interactions — certain peptide combinations produce effects greater than the sum of their individual contributions

Multi-peptide formulations like the Glow blend are particularly valuable for researchers investigating combination effects, as they provide a standardized, co-formulated mixture that ensures consistent ratios across experimental runs. For researchers interested in peptide combination approaches more broadly, our peptide stacking guide covers general principles of multi-peptide protocol design.

Matrixyl and Palmitoyl Peptides: Signal Peptides for Matrix Renewal

Matrixyl and related palmitoyl peptides belong to the category of signal peptides (also called matrikines) — peptide fragments of extracellular matrix proteins that signal cells to produce new matrix components. This mechanism represents a form of biological feedback: when matrix proteins are degraded, the resulting fragments serve as signals to synthesize replacements.

Matrixyl (Palmitoyl Pentapeptide-4 / Pal-KTTKS)

The KTTKS sequence is a fragment of the Type I procollagen C-propeptide. When this fragment is detected by fibroblasts, it signals that collagen has been degraded and that new synthesis is needed. The palmitoyl modification (C16 fatty acid) enhances skin penetration by increasing lipophilicity.

Key research findings on Matrixyl:

• Stimulated Type I collagen synthesis by 117% and Type III collagen synthesis by 327% in cultured human fibroblasts at 2.5 ppm concentration (Robinson et al., 2005)
• Increased fibronectin synthesis by 500% — important for cell adhesion and migration
• In a 6-month vehicle-controlled study, 3% Matrixyl cream produced wrinkle reduction comparable to 0.07% retinol without irritation side effects
• Stimulated hyaluronic acid synthesis, contributing to improved skin hydration

Matrixyl 3000

A more advanced formulation combining two peptides:

• Palmitoyl tripeptide-1 (Pal-GHK) — collagen synthesis stimulation via TGF-? activation
• Palmitoyl tetrapeptide-7 — anti-inflammatory (IL-6 suppression), preserves dermal-epidermal junction

This combination addresses both matrix production (tripeptide-1) and matrix preservation (tetrapeptide-7), providing a balanced approach to dermal regeneration.

Matrixyl Synthe’6

Contains palmitoyl tripeptide-38, which stimulates the synthesis of six key matrix components simultaneously: collagen I, collagen III, collagen IV, fibronectin, hyaluronic acid, and laminin-5. This broad-spectrum matrix stimulation makes it one of the most comprehensive single-peptide ingredients for structural skin rejuvenation.

Melanotan II and Skin Effects

Melanotan II (MT-II) is a synthetic analog of alpha-melanocyte-stimulating hormone (?-MSH) that acts on melanocortin receptors (MC1R-MC5R). While primarily studied for its effects on melanogenesis (skin pigmentation), Melanotan II has several additional skin-relevant effects that warrant discussion in the context of skin rejuvenation research.

Melanogenesis and Photoprotection

MT-II binds MC1R on melanocytes, stimulating eumelanin (brown/black melanin) production via the cAMP/PKA/MITF pathway. This increased melanin production enhances the skin’s natural UV protection — eumelanin absorbs UV radiation and scavenges free radicals generated by UV exposure. In this sense, MT-II provides an endogenous photoprotective effect that complements external UV protection measures.

However, the relationship between melanogenesis and skin rejuvenation is complex:

• Potential benefit: increased eumelanin reduces UV-induced DNA damage and MMP activation, potentially slowing photoaging
• Potential concern: melanocyte stimulation requires careful consideration in the context of pre-existing melanocytic lesions

Anti-Inflammatory Effects via Melanocortin Receptors

Beyond MC1R, Melanotan II activates MC3R and MC4R, which are expressed on immune cells. Melanocortin receptor activation on macrophages and T cells suppresses pro-inflammatory cytokine production and promotes anti-inflammatory responses. This melanocortin anti-inflammatory pathway is well-characterized and represents a mechanism by which MT-II could contribute to reduced inflammaging in skin tissue (Getting et al., 2006; PMID: 17015226).

Comparison with Conventional Anti-Aging Ingredients

To contextualize peptide-based approaches, it is valuable to compare them with established anti-aging ingredients.

Peptides vs. Retinol/Retinoids

As discussed in the GHK-Cu section and in our detailed GHK-Cu vs. retinol comparison, retinoids remain the most evidence-backed topical anti-aging ingredient class. However, peptides offer distinct advantages: no irritation, no photosensitivity, broader gene expression effects (GHK-Cu), and wound-healing support rather than impairment. Many researchers now view peptides and retinoids as complementary rather than competitive — different tools for different aspects of the aging cascade.

Peptides vs. Vitamin C (Ascorbic Acid)

Factor	Bioactive Peptides (GHK-Cu, Matrixyl)	Vitamin C (L-Ascorbic Acid)
Collagen mechanism	Gene expression upregulation (transcriptional level)	Cofactor for prolyl and lysyl hydroxylase (post-translational modification)
Antioxidant mechanism	SOD enzyme upregulation (GHK-Cu)	Direct radical scavenging (stoichiometric, consumed in process)
Stability	Relatively stable (especially palmitoyl derivatives)	Highly unstable (oxidizes rapidly, pH-sensitive)
Penetration	Variable (MW dependent; GHK-Cu ~403 Da penetrates well)	Good at low pH (< 3.5), poor at physiologic pH
Pigmentation effects	Minimal (GHK-Cu); melanogenic (Melanotan II)	Tyrosinase inhibition (brightening)
Irritation	Very low	Moderate at effective concentrations (pH ~2.5-3.5)
Synergy potential	High (different mechanisms complement vitamin C)	High (different mechanisms complement peptides)

The complementary mechanisms of peptides and vitamin C make them excellent combination partners. Peptides drive collagen gene expression, while vitamin C provides the biochemical cofactor (ascorbate) necessary for proper procollagen hydroxylation and cross-linking. A protocol combining GHK-Cu (gene expression), Matrixyl (matrikine signaling), and vitamin C (enzymatic cofactor) addresses collagen production at three different biological levels.

Peptides vs. Hyaluronic Acid

Factor	Bioactive Peptides	Hyaluronic Acid (HA)
Primary effect	Cell signaling, gene expression, matrix production stimulation	Hydration (holds 1000x its weight in water)
Depth of action	Dermal (fibroblast-level effects)	Epidermal/superficial dermal (depending on molecular weight)
Duration	Sustained (gene expression changes persist hours to days)	Transient (requires constant reapplication)
Collagen effect	Direct stimulation	Indirect — improved hydration may support collagen production
Anti-aging mechanism	Addresses root causes (gene expression, growth factors)	Addresses symptom (dehydration, surface texture)
Molecular weight	Small (150-3000 Da)	Very large (>1 million Da for high MW HA; 5,000-50,000 Da for low MW HA)

HA and peptides serve fundamentally different roles. HA provides immediate visible improvement through hydration (“plumping”), while peptides work at the cellular signaling level for longer-term structural improvement. They are highly complementary — HA’s hydration effects improve the dermal microenvironment in which peptides act, and peptides stimulate endogenous HA production by upregulating hyaluronan synthase enzymes.

Delivery Methods: Topical vs. Injection vs. Microneedling

The route of delivery significantly influences the efficacy of skin rejuvenation peptides. Each method has distinct advantages and limitations that researchers must consider.

Topical Application

Advantages: Non-invasive, easy to apply, suitable for large surface areas, good compliance, low risk of systemic effects.
Limitations: Stratum corneum barrier limits penetration (especially for peptides >500 Da), variable absorption depending on formulation vehicle and skin condition, lower dermal concentrations than injection.
Best suited for: Small peptides (GHK-Cu, palmitoyl peptides), daily maintenance protocols, broad surface area treatment.

Topical peptide concentrations must account for the approximately 1-10% penetration rate through intact stratum corneum. This means that a 0.5% GHK-Cu cream delivers roughly 0.005-0.05% of the applied peptide to the viable epidermis and dermis — still within the effective concentration range demonstrated in cell culture studies, but illustrating why formulation science is critical.

Intradermal/Subcutaneous Injection

Advantages: Bypasses stratum corneum entirely, achieves high local concentrations, precise depth targeting, compatible with any peptide size.
Limitations: Invasive, risk of infection/bruising, requires sterile technique, limited to small treatment areas per session, requires trained administrator.
Best suited for: Research protocols requiring high local concentrations, combination with other injectable procedures, targeted treatment of specific areas.

Mesotherapy-style intradermal injection of peptide cocktails has been studied for skin rejuvenation, with protocols typically involving serial treatments at 1-4 week intervals. Research-grade peptides such as GHK-Cu can be reconstituted with bacteriostatic water for injection protocols, following proper sterile reconstitution procedures detailed in our reconstitution guide.

Microneedling-Enhanced Delivery

Advantages: Creates transient microchannels (0.25-2.5 mm depth) that dramatically increase peptide penetration (10-100x), stimulates endogenous collagen induction independently of any applied product, semi-invasive with rapid recovery.
Limitations: Requires device and technique, transient barrier disruption (12-24 hours), risk of infection if sterility is not maintained, not suitable for active acne or infection.
Best suited for: Combining the collagen-induction benefits of microneedling with the specific signaling effects of applied peptides.

The combination of microneedling with GHK-Cu application is particularly compelling from a mechanistic standpoint. Microneedling creates a controlled wound response that includes inflammation, growth factor release, and neocollagenesis. GHK-Cu applied immediately post-needling enters through the microchannels and can modulate this wound response — enhancing collagen production (already stimulated by the needling itself), accelerating healing, and reducing post-inflammatory hyperpigmentation through anti-inflammatory mechanisms.

A 2018 split-face study comparing microneedling alone vs. microneedling with growth factor serum showed significant additional improvement in fine lines, skin texture, and collagen density (as measured by histology) in the growth factor-treated side (Shin et al., 2018; PMID: 29340589). This supports the principle that combining physical collagen induction with biochemical peptide signaling produces superior outcomes.

Comparative Summary of Delivery Methods

Parameter	Topical	Injection	Microneedling
Penetration depth	Epidermis, superficial dermis	Controllable (intradermal to subcutaneous)	Mid-dermis (0.25-2.5 mm)
Delivery efficiency	1-10% of applied dose	~100% at target depth	10-80% (depends on needle depth and density)
Invasiveness	None	Moderate	Mild
Recovery time	None	1-3 days (bruising possible)	12-48 hours (erythema)
Frequency	Daily (1-2x)	Every 1-4 weeks	Every 2-6 weeks
Independent collagen induction	No	No	Yes (wound response triggers neocollagenesis)
Peptide size limitation	< 500 Da optimal	No limitation	Minimal limitation

Clinical Evidence for Peptide-Based Skin Rejuvenation

The evidence base for skin rejuvenation peptides varies significantly by compound. The following summarizes key clinical and translational findings.

GHK-Cu Clinical Evidence

• Wrinkle reduction: In a 12-week double-blind study, GHK-Cu cream significantly improved fine lines, wrinkle depth, and skin density compared to placebo and vitamin K oxide. Ultrasound measurements confirmed increased dermal thickness (Leyden et al., 2002).
• Skin tightening: GHK-Cu cream produced improvements in skin laxity and firmness comparable to tretinoin cream in a comparative study, without the irritation side effects.
• Post-procedural healing: Application of GHK-Cu after laser resurfacing reduced healing time, erythema duration, and post-inflammatory hyperpigmentation in pilot studies.
• Photoaging reversal: Electron microscopy studies showed that GHK-Cu treatment increased normal-appearing collagen fiber bundles and elastic fibers in photoaged skin biopsies.

Matrixyl Clinical Evidence

• In a 6-month study, twice-daily application of 8 ppm Matrixyl reduced wrinkle volume by 36% and wrinkle depth by 27%, with improvements beginning as early as 2 months (Robinson et al., 2005).
• A comparative study found Matrixyl comparable to retinol in wrinkle reduction efficacy but with significantly better tolerability.
• Combination studies pairing Matrixyl with vitamin C and HA showed additive effects on wrinkle reduction and skin firmness.

EGF and Growth Factor Clinical Evidence

• Recombinant human EGF (rhEGF) cream improved periorbital wrinkles by 33% over 8 weeks in a Korean split-face study (Shin et al., 2013; PMID: 24049263).
• A growth factor serum containing multiple growth factors (EGF, FGF, VEGF, TGF-?, PDGF) improved skin roughness, hydration, and elasticity in a 60-day study of women aged 35-65 (Fitzpatrick et al., 2009; PMID: 20412587).
• Post-fractional-laser application of growth factor serums reduced healing time from 5 days to 3 days and reduced post-procedural erythema.

Thymosin Beta-4 in Wound Healing

TB-500 (Thymosin Beta-4) has been studied in clinical trials for dermatological wound healing applications. RegeneRx Biopharmaceuticals completed Phase 2 trials of topical T?4 (RGN-137) for epidermolysis bullosa and chronic wounds, demonstrating accelerated wound closure and improved pain scores compared to standard care (Dunn et al., 2010; PMID: 20536470). These findings support the role of T?4 in skin repair and suggest potential applications in anti-aging contexts where wound healing mechanisms overlap with rejuvenation.

Anti-Aging Protocol Design: A Research Framework

Designing effective skin rejuvenation research protocols requires integrating multiple peptide mechanisms, delivery methods, and assessment tools. The following framework is provided for educational and research design purposes.

Layer 1: Daily Topical Protocol

Time	Product	Purpose	Key Active
Morning	Vitamin C serum (15-20% L-AA, pH 2.5-3.5)	Antioxidant protection, collagen cofactor	L-Ascorbic acid
Morning	Peptide serum (GHK-Cu 0.1-0.5% + Matrixyl 3-8 ppm)	Collagen gene expression, matrikine signaling	GHK-Cu, Pal-KTTKS
Morning	Broad-spectrum SPF 30-50	UV protection (prevents new photoaging damage)	UV filters
Evening	Retinoid (0.025-0.1% tretinoin or 0.5-1% retinol)	Cell turnover, additional collagen stimulation	Retinoid
Evening	Peptide cream (GHK-Cu + growth factors)	Overnight matrix remodeling, repair support	GHK-Cu, growth factors

Layer 2: Weekly/Biweekly Enhancement

Intervention	Frequency	Purpose	Peptide Integration
At-home microneedling (0.25-0.5 mm)	1-2x/week	Enhanced peptide penetration, mild collagen induction	Apply GHK-Cu serum immediately after
LED red light therapy (630-660 nm)	3-5x/week	Mitochondrial stimulation, fibroblast activation	Apply peptide serum before LED session

Layer 3: Monthly Professional Enhancement

Procedure	Frequency	Peptide Integration
Professional microneedling (1.0-2.0 mm)	Monthly	Post-procedure GHK-Cu application + growth factor serum
Mesotherapy (intradermal peptide injection)	Monthly	GHK-Cu + hyaluronic acid intradermal delivery
Chemical peel (glycolic 30-50%)	Every 4-6 weeks	Post-peel peptide application for enhanced penetration through thinned stratum corneum

Layer 4: Systemic Support (Research Context)

In research contexts investigating the interplay between systemic peptide administration and skin outcomes, several peptides may be relevant:

• GHK-Cu (subcutaneous) — systemic administration provides GHK-Cu to dermal fibroblasts via the bloodstream, complementing topical delivery
• BPC-157 — systemic cytoprotection, angiogenesis, and growth factor modulation support skin healing from within. See our BPC-157 research guide for detailed information.
• MOTS-C — mitochondrial peptide that enhances cellular energy metabolism, potentially supporting the energy-intensive processes of collagen synthesis and tissue repair
• CJC-1295 + Ipamorelin — growth hormone secretagogues that increase GH/IGF-1 levels, supporting collagen synthesis, skin thickness, and overall tissue regeneration

For the latest advances in peptide research relevant to skin rejuvenation, see our coverage of peptide research breakthroughs in 2025-2026.

Detailed Comparison Tables: Skin Rejuvenation Peptides

The following tables provide at-a-glance comparisons for researchers evaluating different peptide options for skin rejuvenation studies.

Mechanism Comparison

Peptide	Collagen Synthesis	MMP Inhibition	Antioxidant	Anti-Inflammatory	Wound Healing	Angiogenesis
GHK-Cu	Strong (Types I, III, IV)	Strong (context-dependent)	Strong (SOD1/2/3 upregulation)	Strong	Strong	Moderate
Matrixyl (Pal-KTTKS)	Strong (Types I, III)	Moderate	None	None	Moderate	None
Matrixyl 3000	Strong	Moderate	None	Moderate (IL-6 suppression)	Moderate	None
EGF	Moderate	Weak	None	Weak	Strong	Moderate
bFGF (FGF-2)	Strong	Weak	None	Weak	Strong	Strong
BPC-157	Moderate	Moderate	Moderate (via NO modulation)	Strong	Strong	Strong
TB-500	Weak	Promotes (for remodeling)	None	Strong	Strong	Strong
Argireline	Moderate	None	None	None	None	None
Melanotan II	None	None	None (eumelanin has antioxidant properties)	Moderate (melanocortin pathway)	Weak	None

Practical Comparison

Peptide	Molecular Weight (Da)	Topical Penetration	Stability	Optimal Delivery	Evidence Level
GHK-Cu	~403	Good (<500 Da threshold)	Good (copper stabilizes)	Topical, injection, microneedling	Multiple clinical studies
Matrixyl	~803	Moderate (palmitoyl enhances)	Good	Topical (serum/cream)	Multiple clinical studies
EGF	~6,200	Poor (too large)	Moderate	Injection, microneedling, liposomal	Clinical studies (wound healing)
bFGF	~17,000	Very poor	Low (heat-sensitive)	Injection only	Clinical studies (wound healing)
BPC-157	~1,419	Poor-moderate	Good (acid-stable)	Injection, oral	Extensive preclinical
TB-500	~4,963	Poor	Good	Injection	Phase 2 clinical (wounds)
Argireline	~889	Moderate	Good	Topical	Multiple clinical studies

Special Topic: Copper Peptides and Hair Research

GHK-Cu’s effects extend beyond facial skin rejuvenation into hair follicle biology. Copper peptides have been shown to:

• Increase hair follicle size in organ culture models
• Stimulate dermal papilla cells (the key regulatory cells of the hair follicle)
• Prolong the anagen (growth) phase of the hair cycle
• Increase vascularization around hair follicles (supporting nutrient delivery)
• Modulate 5-alpha-reductase activity (the enzyme that converts testosterone to DHT)

For a comprehensive review of this topic, see our dedicated guide on copper peptides and hair loss research.

Safety Considerations for Skin Rejuvenation Peptides

The safety profile of skin rejuvenation peptides is generally favorable, but researchers should be aware of several considerations.

Topical Peptide Safety

• Irritation potential: Most peptides have very low irritation potential compared to retinoids, alpha-hydroxy acids, or vitamin C at effective concentrations. GHK-Cu, Matrixyl, and Argireline are well-tolerated even by sensitive skin.
• Allergic reactions: Rare but possible, particularly with peptides of non-human origin or those containing novel chemical modifications. Patch testing is recommended before full-face application in research subjects.
• Copper sensitivity: GHK-Cu contains copper, and individuals with copper hypersensitivity (e.g., Wilson disease carriers) should avoid copper-containing products. Normal copper intake from topical GHK-Cu is negligible compared to dietary copper exposure.

Injectable Peptide Safety

• Sterility: All injectable peptide preparations must be reconstituted and administered under sterile conditions. Use bacteriostatic water for reconstitution and follow proper aseptic technique.
• Injection site reactions: Mild erythema, swelling, and bruising at injection sites are common and typically resolve within 24-48 hours.
• Systemic effects: At research doses, systemic effects from localized peptide injections are generally minimal due to low total doses and rapid local metabolism.

Growth Factor Safety Considerations

Growth factor peptides (EGF, FGF, TGF-?) require particular attention regarding their potential effects on cell proliferation. While topical application at cosmetic concentrations has not been associated with adverse proliferative effects in published studies, the theoretical concern remains relevant for researchers working with higher concentrations or injectable formulations. Exclusion of subjects with active or history of skin cancer is a standard precaution in growth factor research protocols.

Frequently Asked Questions

What is the most effective single peptide for skin rejuvenation?

Based on the breadth of mechanisms and clinical evidence, GHK-Cu is the most comprehensively effective single peptide for skin rejuvenation. Its ability to modulate 4,000+ genes — including those governing collagen synthesis, antioxidant defense, inflammation, and DNA repair — gives it the broadest mechanism of action of any characterized skin peptide. However, multi-peptide approaches consistently outperform single-peptide protocols, as they address multiple aging mechanisms simultaneously.

Can peptides replace retinol in anti-aging protocols?

Peptides and retinol work through different mechanisms and are best viewed as complementary rather than substitutes. For individuals who cannot tolerate retinoids (due to irritation, photosensitivity, pregnancy, or other concerns), peptides like GHK-Cu and Matrixyl offer effective alternatives with better tolerability profiles. For those who can tolerate retinoids, adding peptides provides additional mechanisms of action not covered by retinoids alone. See our detailed GHK-Cu vs. retinol comparison for more.

How long does it take to see results from skin rejuvenation peptides?

Clinical studies show measurable improvements beginning at 4-8 weeks, with optimal results at 12-24 weeks of consistent use. Hydration and texture improvements may be noticeable within 2-4 weeks, while collagen-mediated improvements in firmness, wrinkle depth, and skin density require the longer timeframes associated with collagen synthesis and maturation (approximately 4-6 months for full collagen fiber remodeling).

Is microneedling necessary for peptide efficacy, or does topical application work?

Topical application of appropriately formulated peptides (especially small peptides like GHK-Cu and lipophilic peptides like palmitoyl derivatives) is effective on its own, as demonstrated in clinical studies using topical-only protocols. Microneedling enhances delivery 10-100x and provides independent collagen induction benefits, making it a powerful adjunct. However, it is not required for peptide efficacy.

Can GHK-Cu and BPC-157 be used together for skin rejuvenation?

GHK-Cu and BPC-157 target overlapping but distinct pathways in skin repair. GHK-Cu provides broad gene expression modulation and collagen synthesis stimulation, while BPC-157 contributes potent angiogenic, anti-inflammatory, and cytoprotective effects. Together, they address structural matrix production (GHK-Cu), vascular support for nutrient delivery (BPC-157), and comprehensive anti-inflammatory protection (both). This combination can be explored with topical GHK-Cu and subcutaneous BPC-157, or with the addition of the Wolverine Blend for systemic healing support.

What role does the Glow peptide blend play in skin research?

The Glow peptide blend provides a multi-component approach to skin rejuvenation research, combining complementary peptides in a standardized formulation. This is particularly valuable for researchers investigating combination effects, as it eliminates the variability associated with mixing individual components. The blend approach reflects the growing consensus that multi-target interventions are more effective than single-target approaches for complex biological processes like skin aging.

Are collagen supplements (oral collagen peptides) effective for skin?

Oral collagen peptide supplements (hydrolyzed collagen) represent a distinct approach from topical or injectable bioactive peptides. Several randomized controlled trials have shown that oral collagen peptide supplementation (2.5-10 g/day for 8-12 weeks) improves skin hydration, elasticity, and wrinkle depth compared to placebo (Proksch et al., 2014; PMID: 23949208). The mechanism appears to involve dipeptide fragments (Pro-Hyp, Hyp-Gly) acting as matrikine signals to dermal fibroblasts. However, these are dietary supplements distinct from the research-grade peptides discussed in this article.

What is the best way to store skin rejuvenation peptides?

Lyophilized peptides should be stored at -20°C for long-term stability. After reconstitution with bacteriostatic water, store at 2-8°C (refrigerator) and use within the recommended timeframe (typically 10-21 days depending on the peptide). Topical peptide formulations should follow manufacturer storage recommendations. Avoid repeated freeze-thaw cycles, which can denature peptide structures. For comprehensive storage guidance, see our peptide storage and temperature guide.

Conclusion: The Future of Peptide-Based Skin Rejuvenation

Peptides for skin rejuvenation represent a paradigm shift from symptomatic treatment (moisturizing, exfoliating) to mechanistic intervention (gene expression modulation, targeted pathway activation, growth factor signaling). The field has matured significantly from the early days of simple collagen-fragment peptides to today’s sophisticated understanding of multi-target, multi-pathway rejuvenation strategies.

Key takeaways from this comprehensive review include:

• GHK-Cu stands alone as the most broadly effective single skin peptide, modulating 4,000+ genes toward a more youthful expression pattern while stimulating collagen synthesis, activating antioxidant defense, and reducing inflammation.
• Signal peptides (Matrixyl, palmitoyl peptides) provide targeted matrikine signaling to stimulate specific matrix protein production, and are well-suited for topical delivery.
• Growth factor peptides (EGF, FGF, TGF-? fragments) offer potent but more specialized effects, best deployed as part of multi-peptide protocols.
• Multi-peptide approaches consistently outperform single-peptide protocols, as skin aging involves multiple simultaneous pathways that benefit from multi-target intervention. Products like the Glow blend exemplify this approach.
• Delivery method dramatically affects efficacy — topical for daily maintenance, microneedling for enhanced delivery and collagen induction, injection for maximum local concentration.
• Systemic peptides like BPC-157, TB-500, and MOTS-C can complement topical approaches by supporting skin health from the inside through angiogenesis, anti-inflammation, and metabolic optimization.

As research continues to elucidate the molecular mechanisms of skin aging and the precise ways in which peptides modulate these processes, the field moves ever closer to truly evidence-based, personalized skin rejuvenation protocols. Researchers can explore the full range of peptides discussed in this guide through the Proxiva Labs catalog, and stay current with developments via our research hub.

References

1. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. PMID: 25866791
2. Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: resetting the human genome to health. Biomed Res Int. 2014;2014:151479. PMID: 24971312
3. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. PMID: 18644225
4. Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-346. PMID: 3169264
5. Varani J, Dame MK, Rittie L, et al. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol. 2006;168(6):1861-1868. PMID: 16723701
6. Uitto J. Connective tissue biochemistry of the aging dermis. Age-related alterations in collagen and elastin. Dermatol Clin. 1986;4(3):433-446. PMID: 3521988
7. Shin JW, Kwon SH, Choi JY, et al. Molecular mechanisms of dermal aging and antiaging approaches. Int J Mol Sci. 2019;20(9):2126. PMID: 31036793
8. Katayama K, Armendariz-Borunda J, Raghow R, et al. A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem. 1993;268(14):9941-9944. PMID: 8245302
9. Shin JU, Oh SH, Lee JH. Topical recombinant human epidermal growth factor for the treatment of periorbital wrinkles. J Dermatolog Treat. 2013;24(4):268-272. PMID: 24049263
10. Akita S, Akino K, Imaizumi T, Hirano A. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen. 2008;16(5):635-641. PMID: 18844727
11. Getting SJ, Christian HC, Lam CW, et al. Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor. J Immunol. 2003;170(6):3323-3330. PMID: 12626593
12. Proksch E, Segger D, Degwert J, et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55. PMID: 23949208
13. Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003;5(1):25-34. PMID: 12745596
14. Robinson LR, Fitzgerald NC, Piacquadio DG, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005;27(3):155-160. PMID: 18492182
15. Dunn SP, Heidemann DG, Chow CY, et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin ?4. Ann N Y Acad Sci. 2010;1194:199-206. PMID: 20536470
16. Bock-Marquette I, Saxena A, White MD, DiMaio JM, Srivastava D. Thymosin ?4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-472. PMID: 15340215
17. Malinda KM, Sidhu GS, Mani H, et al. Thymosin ?4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. PMID: 10469334
18. Leyden J, Stephens T, Finkey M, et al. Skin care benefits of copper peptide containing facial cream. Cosmetic Dermatol. 2002;15:28-34.
19. Shin MK, Lee JH, Lee SJ, Kim NI. Platelet-rich plasma combined with fractional laser therapy for skin rejuvenation. Dermatol Surg. 2012;38(4):623-630. PMID: 22243434
20. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin ?4: a multi-functional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51. PMID: 22515943

This article is provided for educational and research purposes only. Peptides discussed are sold for laboratory research use and are not intended for human consumption. Nothing in this article constitutes medical or dermatological advice. Consult appropriate professionals and review boards before designing research protocols. Browse our full selection of research peptides at the Proxiva Labs catalog.